InvestorsHub Logo
Followers 19
Posts 1284
Boards Moderated 0
Alias Born 04/03/2020

Re: SmileyRiley_595 post# 81799

Tuesday, 06/02/2020 11:01:20 AM

Tuesday, June 02, 2020 11:01:20 AM

Post# of 233508
There still is a PDUFA review for this application. It has not been approved. Cytodyn has asked for priority review, which hopefully will speed up the process, but it's not approved.

https://www.nuventra.com/resources/blog/regulatory-differences-between-an-nda-bla/

To formally request approval to market a new drug in the United States, sponsors must submit either a New Drug Application (NDA) or a Biologics License Application (BLA) to the FDA. As their names suggest, BLAs relate to biological products while NDAs generally pertain to traditional small molecule drugs.

Not approved yet! Yet...



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News